ArticleCancers2022
Concomitant Inhibition of FASN and SREBP Provides a Promising Therapy for CTCL.
Cheng Chi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ArticleCancers2022
Cheng Chi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.